Movement Alert|Salesforce.com Rises 3.11% in Regular Trading, Q2 Earnings Beat and Analyst Upgrades Extend Rally

Market Focus
Aug 28

On August 28, Salesforce.com rose 3.11% in regular trading, trading at $258.608/share with turnover of $1.624 billion, extending gains after a 22.58% surge in the prior session following blowout Q2 results.

The continued strength is driven by a wave of institutional price target upgrades following the company's fiscal Q2 earnings beat. Truist Securities raised its target to $300, TD Cowen to $280, and Loop Capital to $250. Salesforce reported Q2 revenue of $11.35 billion, up 11% year-over-year, with adjusted EPS of $5.90 versus consensus of $3.27. The company raised full-year revenue guidance to $46.1-$46.4 billion and EPS guidance to $16.67-$16.71, far exceeding prior consensus of $14.17. Additionally, the expanded Anthropic partnership launching Claudeforce and AI/data product ARR approaching $4 billion reinforced confidence in AI monetization. UBS noted the results eased concerns that AI tools may erode demand for traditional software, though Bank of America maintained a cautious stance citing the limited absolute scale of Agentforce ARR relative to the revenue base.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10